OREANDA-NEWS. Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) ("Pharmstandard" or/and the "Company") announces that pursuant to the Company's buyback program, announced on February 15, 2013 (further the "Program"), 15 009 162 GDRs and 140 000 ordinary shares were purchased on the open market as of July 16, 2013. All purchases of GDRs were made by an independent broker Citigroup Global Markets Limited for the account of Pharmstandard-Leksredstva OJSC, an indirect wholly owned subsidiary of the Company.

Therefore, since the start of Pharmstandard's buyback program the following securities have been purchased:

The last buy-back took place on July 16: 2 191 787 GDRs at the price of 13,60 USD per GDR.

The Program was approved in respect of ordinary shares of Pharmstandard OJSC and/or Global Depositary Receipts representing Shares (each Share representing 4 GDRs) in the aggregate amount of up to RUR8 billion. Duration of program: December 31, 2013.

The total sum of securities purchased as of July 16, 2013 constitutes RUR 8 018 448 800,49, hence, the Programs may be considered as completed.